Apex Biotechnology Corp (1733) — Cash Flow Reinvestment Rate
Apex Biotechnology Corp (1733) has a Cash Flow Reinvestment Rate of 1.77x as of September 2025, reinvesting NT$9.17 Million (capex NT$2.97 Million plus investments NT$6.21 Million) from operating cash flow of NT$5.19 Million. Explore Apex Biotechnology Corp capital spending ratio to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Apex Biotechnology Corp Cash Flow Reinvestment Rate (2002–2024)
Historical reinvestment intensity for Apex Biotechnology Corp across 23 annual periods. Also explore how large is Apex Biotechnology Corp's balance sheet for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Apex Biotechnology Corp (2002–2024)
Year-by-year capital reinvestment analysis for Apex Biotechnology Corp. For live market cap and broader valuation context, see Apex Biotechnology Corp stock valuation.
| Year | Reinvestment Rate | Total Reinvested (TWD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.11x | NT$35.63 Million | NT$328.67 Million | NT$29.63 Million | ▼ -47.4% |
| 2023 | 0.21x | NT$47.48 Million | NT$230.39 Million | NT$24.98 Million | ▼ -86.6% |
| 2022 | 1.54x | NT$40.90 Million | NT$26.62 Million | NT$40.20 Million | ▲ +880.3% |
| 2021 | 0.16x | NT$28.20 Million | NT$179.87 Million | NT$26.20 Million | ▼ -74.4% |
| 2020 | 0.61x | NT$171.51 Million | NT$280.60 Million | NT$48.32 Million | ▲ +112.3% |
| 2019 | 0.29x | NT$133.19 Million | NT$462.52 Million | NT$56.58 Million | ▼ -81.6% |
| 2018 | 1.56x | NT$105.52 Million | NT$67.57 Million | NT$75.29 Million | ▲ +312.9% |
| 2017 | 0.38x | NT$26.79 Million | NT$70.83 Million | NT$26.76 Million | ▲ +101.2% |
| 2016 | 0.19x | NT$56.03 Million | NT$298.06 Million | NT$38.45 Million | ▼ -5.2% |
| 2015 | 0.20x | NT$93.63 Million | NT$472.15 Million | NT$26.66 Million | ▼ -44.4% |
| 2014 | 0.36x | NT$95.47 Million | NT$267.60 Million | NT$65.41 Million | ▼ -40.9% |
| 2013 | 0.60x | NT$292.47 Million | NT$484.77 Million | NT$247.69 Million | ▼ -25.9% |
| 2012 | 0.81x | NT$414.70 Million | NT$509.67 Million | NT$414.70 Million | ▲ +198.1% |
| 2011 | 0.27x | NT$74.63 Million | NT$273.45 Million | NT$74.63 Million | ▼ -21.1% |
| 2010 | 0.35x | NT$161.05 Million | NT$465.59 Million | NT$161.05 Million | ▲ +84.6% |
| 2009 | 0.19x | NT$73.34 Million | NT$391.29 Million | NT$73.34 Million | ▼ -56.7% |
| 2008 | 0.43x | NT$129.74 Million | NT$299.96 Million | NT$129.74 Million | ▲ +188.3% |
| 2007 | 0.15x | NT$54.71 Million | NT$364.62 Million | NT$54.71 Million | ▲ +30.0% |
| 2006 | 0.12x | NT$41.99 Million | NT$363.71 Million | NT$41.99 Million | ▼ -69.9% |
| 2005 | 0.38x | NT$81.30 Million | NT$212.14 Million | NT$81.30 Million | ▼ -66.7% |
| 2004 | 1.15x | NT$251.16 Million | NT$218.54 Million | NT$251.16 Million | ▲ +518.0% |
| 2003 | 0.19x | NT$56.21 Million | NT$302.25 Million | NT$56.21 Million | ▼ -75.8% |
| 2002 | 0.77x | NT$61.13 Million | NT$79.49 Million | NT$61.13 Million | — |